Back to Search
Start Over
Aligos Therapeutics is awarded EUR1.8M VLAIO grant to advance chronic hepatitis B research
- Source :
- GlobeNewswire. November 12, 2020
- Publication Year :
- 2020
-
Abstract
- SOUTH SAN FRANCISCO, Calif. and LEUVEN, Belgium, Nov 12, 2020 (GLOBE NEWSWIRE via COMTEX) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on developing novel therapeutics [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- GlobeNewswire
- Publication Type :
- News
- Accession number :
- edsgcl.641281117